Pharmabiz7m
New data reveals BD's artificial intelligence software highly effective in detecting indicators of controlled substance diversion
Franklin Lakes, New Jersey Friday, September 27, 2024, 15:00 Hrs [IST] ...
Pharmabiz1h
WHO releases guidance to improve the design, conduct and oversight of clinical trials
WHO releases guidance to improve the design, conduct and oversight of clinical trials: Geneva Friday, September 27, 2024, 14:00 Hrs [IST] The World Health Organization (WHO) relea ...
Pharmabiz1h
Researchers see new generation therapeutics to propel precision medicine
Researchers see a greater need for new generation therapeutics to propel precision medicine. The development of innovative therapeutic approaches in healthcare encompass a variety of fields, including ...
Pharmabiz2h
Boehringer Ingelheim expands cancer research at its Vienna site
Boehringer Ingelheim expands cancer research at its Vienna site: Ingelheim, Germany Friday, September 27, 2024, 13:00 Hrs [IST] Boehringer Ingelheim, one of the world's leading re ...
Pharmabiz3h
Roche announces positive results from phase III study of Gazyva/Gazyvaro in people with lupus nephritis
Roche announces positive results from phase III study of Gazyva/Gazyvaro in people with lupus nephritis: Basel Friday, September 27, 2024, 12:00 Hrs [IST] Roche announced positive ...
Pharmabiz3h
Care.fi secures Rs. 8 crore impact debt funding to accelerate growth in Indian healthcare-focused fintech sector
Care.fi secures Rs. 8 crore impact debt funding to accelerate growth in Indian healthcare-focused fintech sector: Our Bureau, Mumbai Friday, September 27, 2024, 11:45 Hrs [IST] Ca ...
Pharmabiz3h
Stryker introduces 1788, next generation of advanced surgical camera in India, elevating surgical visualization across specialties
Stryker introduces 1788, next generation of advanced surgical camera in India, elevating surgical visualization across specialties: Our Bureau, Mumbai Friday, September 27, 2024, ...
Pharmabiz4h
US FDA approves AstraZeneca’s Tagrisso for patients with unresectable, stage III EGFR-mutated lung cancer
US FDA approves AstraZeneca’s Tagrisso for patients with unresectable, stage III EGFR-mutated lung cancer: Cambridge, UK Friday, September 27, 2024, 11:00 Hrs [IST] AstraZenecas ...
Pharmabiz5h
Pfizer voluntarily withdraws all lots of sickle cell disease treatment Oxbryta from worldwide markets
Pfizer voluntarily withdraws all lots of sickle cell disease treatment Oxbryta from worldwide markets: New York Friday, September 27, 2024, 10:00 Hrs [IST] Pfizer Inc. announced t ...
Pharmabiz6h
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies: Berlin, Germany Friday, September 27, 2024, 09:00 Hrs [IST] Bayer AG and Asklepios BioPhar ...
Pharmabiz7h
D&C violations galore in Hyderabad, DCA officials crackdown on unlicensed pharmacy and quack’s premises
Peethaambaran Kunnathoor, Chennai Friday, September 27, 2024, 08:00 Hrs [IST] ...
Pharmabiz7h
DoP modifies successor-in-interest clause of PLI scheme for bulk drugs
DoP modifies successor-in-interest clause of PLI scheme for bulk drugs: Gireesh Babu, New Delhi Friday, September 27, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) ...